A Phase 1, Open-Label Study to Assess the Single-Dose Pharmacokinetics of Eravacycline in Subjects With Impaired Hepatic Function and Healthy Subjects
NCT02135302
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
24
Enrollment
INDUSTRY
Sponsor class
Conditions
Impaired Hepatic Function
Interventions
DRUG:
eravacycline
Sponsor
Tetraphase Pharmaceuticals, Inc